Comparison of Neutralizing Sars Cov-2 Igg Antibody Levels in Hospitalized Patients at Dr. Mohammad Hoesin Palembang Hospital

Zen Ahmad, Sudarto Sudarto, Ra Linda, Rouly PP, Alif FR, Syafran Rasyidi, Phey Liana

Sari


ABSTRACT

 

COVID-19 is an acute respiratory disease that spreads rapidly throughout the world caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Published research on levels of SARS-CoV-2 antibodies in hospitalized COVID-19 patients is still limited. Research on sero-epidemiology and its correlation with the clinical severity of COVID-19 is needed as a database for pandemic governance, especially research on neutralizing antibodies. This study was designed to compare the levels of IgG SARS CoV-2 on the tenth day in hospitalized patients with various clinical severity at RSUP Dr. Mohammad Hoesin Palembang. This research is an observational-analytic study with a cross-sectional design. The study was conducted in the COVID-19 isolation ward of RSMH Palembang from December 2021 to March 2022. IgG SARS CoV-2 level was measured in patients with confirmed COVID-19. Differences in IgG values of SARS CoV-2 were tested with the Mann Whitney test. The effect of various confounding variables in this study was tested using bivariate and multivariate tests in the form of a chi-square test and multiple linear regression on the scale of the dependent variable. The study included 50 patients, consisting of 22 patients with mild-moderate severity and 28 patients with severely-critically ill. Bivariate analysis showed there was no significant difference of IgG SARS-CoV-2 between two groups. From the data analysis using the ROC curve, the cut-off point for SARS-CoV-2 IgG levels in predicting the severity of COVID-19 disease was 500 AU/mL. IgG SARS-CoV-2 level of more than 500 AU/mL causes an increased risk of 3.69 (95% CI 1.13-11.98) times to suffer from severe-critical COVID-19. Serum IgG SARS-CoV-2 levels were found to be significantly higher in patients with severe-critical symptoms than patients with mild-moderate symptoms in COVID-19 hospitalized patients at Dr. Mohammad Hoesin Palembang hospital.

 

Keywords: COVID-19, severity of COVID-19, IgG SARS-CoV-2


Teks Lengkap:

Download Artikel

Referensi


Alves Vp, Casemiro Fg, Araujo Bg, Lima Ma, Oliveira Rs, Fernandes Ft, Gomes Av, Gregori D. (2021). Factors Associated With Mortality Among Elderly People In The Covid-19 Pandemic (Sars-Cov-2): A Systematic Review And Meta -Analysis. International Journal Of Environmental Research And Public Health. Jul 29;18(15):8008.

Bao, Yujie, Et Al. (2021). Dynamic Anti-Spike Protein Antibody Profiles In Covid-19 Patients. International Journal Of Infectious Diseases, 103: 540-548.

Costeira R, Lee Ka, Murray B, Christiansen C, Castillo-Fernandez J, Ni Lochlainn M, Capdevila Pujol J, Macfarlane H, Kenny Lc, Buchan I, Wolf J(2021). Estrogen And Covid-19 Symptoms: Associations In Women From The Covid Symptom Study. Plos One. Sep 10;16(9):E0257051.

Covid-19: Latest Update South

Http://Corona.Sumselprov.Go.Id/Index.Php?Module=Home&Id=1. [Online] Accessed June 7, 2021.

Fitrianingsih Aa. (2021). Herd Immunity And Vaccines Against Sars-Cov-2. In: Susanti N, Riskiyah, Ulhaq Zs, Editors. The Covidpedia (Opinion_Reflection_Review_Good_Practice). Print I. Malang: Media Nusa Creative; 71-80.

Higgins V, Fabros A, Kulasingan V.(2021). Quantitative Measurement Of Anti-Sars-Cov-2 Antobodies: Analytical And Clinical Evaluation. Jcm. 59(4):1-20.

Iwasaki A, Yang Y. (2020). The Potential Danger Of Suboptimal Antibody Responses In Covid-19. Nat Rev Immunol 20:339–41.

Jafarzadeh A, Jafarzadeh S, Nozari P, Mokhtari P, Nemati M. (2021). Lymphopenia An Important Immunological Abnormality In Patients With Covid‐ 19: Possible Mechanisms. Scandinavian Journal Of Immunology. Feb;93(2):E12967.

Liu, Li, Et Al. (2020). High Neutralizing Antibody Titer In Intensive Care Unit Patients With Covid-19. Emerging Microbes & Infections, 9.1: 1664-1670.

Marklund E, Leach S, Axelsson H, Nyström K, Norder H, Bemark M, Angeletti D, Lundgren A, Nilsson S, Andersson Lm, Yilmaz A. (2020). Serum-Igg Responses To Sars-Cov-2 After Mild And Severe Covid-19 Infection And Analysis Of Igg Non-Responders. Pls One. Oct 21;15(10):E0241104.

Narasimhan M, Mahimainathan L, Araj E, Clark Ae, Markantonis J, Green A, Xu J, Sorelle Ja, Alexis C, Fankhauser K, Parikh H, Wilkinson K, Reczek A, Kopplin N, Yekkaluri S, Balani J, Thomas A , Singal Ag, Sarode R, Muthukumar A, (2021). Clinical Evaluation Of The Abbott Alinity Sars-Cov-2 Spike-Specific Itative Igg And Igm Assays Among Infected, Recovered, And Vaccinated Groups. J Clin Microbiol 59:E00388-21.Https://Doi.Org/10.1128/Jcm.00388-21.

Omran D, Al Soda M, Bahbah E, Esmat G, Shousha H, Elgebaly A, Abdel Ghaffar M, Alsheikh M, El Sayed E, Afify S, Abdel Hafez S. (2021). Predictors Of Severity And Development Of Critical Illness Of Egyptian Covid-19 Patients: A Multicenter Study. Plos One. Sep 23;16(9):E0256203.

Raharusun P, Priambada S, Budiarti C, Agung E, Budi C. (2020) Patterns Of Covid-19 Mortality And Vitamin D: An Indonesian Study. Ssrn Electron J. Apr 26;7:1-2.

Shi R, Shan C, Duan X, Et Al. A Human Neutralizing Antibody Targets The Receptor Binding Site Of Sars-Cov-2. Nature 2020; 584:120–4. Available At: Https://Doi.Org/10.1038/S41586-020-2381-Y.

Sun J, He Wt, Wang L, Et Al. (2020). Covid-19: Epidemiology, Evolution, And Crossdisciplinary Perspectives. Mol Med Trends 26:483–95.

Trinite, Benjamin, Et Al.(2021). Sars-Cov-2 Infection Eliminates A Rapid Neutralizing Antibody Response That Correlates With Disease Severity. Sci Reports, , 11.1: 1-10.

Wang, Kai, Et Al. (2020). Longitudinal Dynamics Of The Neutralizing Antibody Response To Sars-Cov-2 Infection. Clinical Infectious Diseases,.

Who Coronavirus (Covid-19) Dashboard. (2021). Https://Covid19.Who.Int/. [Online] Accessed June 7.

Who Coronavirus (Covid-19) Indonesia.(2021). Https://Covid19.Who.Int/Region/Searo/Country/Id. [Online] Accessed June 7.

Wirawan, Gede Benny Setia; Januraga, Pande Putu. Correlation Of Demographics, Healthcare Availability, And Covid-19 Outcome: Indonesian Ecological Study. Frontiers In Public Health, 2021, 9.

Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y, Zhang Y. (2020). Covid-19: Immunopathogenesis And Immunotherapeutics. Signal Transduction And Targeted Therapy. Jul 25;5(1):1-8.

Zhang, Xiaoyong, Et Al. (2020). Viral And Antibody Kinetics Of Covid-19 Patients With Different Disease Severities In Acute And Convalescent Phases: A 6-Month Follow-Up Study. Virologica Sinica, 1-10.




DOI: https://doi.org/10.33024/mnj.v5i5.8515

Refbacks

  • Saat ini tidak ada refbacks.


Penerbit: Universitas Malahayati

 Creative Commons License

Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License